USA Ke Keʻena Ulalani, Kanakā Lahui Nā'Ileʻawa, Nā Hana Hana'Aiwi Pākehā

Koina kaʻukea (83919-23-7)

Rating: SKU: 83919-23-7. Māhele:

ʻO AASraw me ka synthesis a me ka hiki ke hoʻomohala mai ka metala a hiki i ka waihona papahoʻi o Mometasone furoate (83919-23-7), ma lalo o ka hoʻoponopono CGMP a me ka ʻōnaehana kāʻei maikaʻi o ka trackable.

Product Description

Mometasone furoate (83919-23-7) wikiō


Momorasone furoate (83919-23-7) Ske kūkala:

Hoʻolālā kūlohelohe: Product Name: Momorasone furoate
Kānāwai No.: 83919-23-7
Ka Lā Molecular: C27H30Cl2O6
Molecular Weight: 521.4
Hōʻuluʻulu Manaʻo:momonee furoate

83919-23-7

Nasonex

Asmanex

Elokona

Puke: Ka pō, pouli
Nā Palapala Kūlana (COA & HPLC etc.): Available

Momorasone furoate (83919-23-7) Dinoa:

ʻO ka Mometasone Furoate ka ʻano paʻakai furoate o ka mometasone, kahi agonist receptor glucocorticosteroid topical me nā anti-inflammatory, anti-pruritic a me nā vasoconstrictive waiwai.

ʻO ka Mometasone furoate e hoʻopuka i kona hopena ma o ka hoʻopaʻa ʻana i nā receptor i ka glucocorticoid cytoplasmic a laila hoʻāla i ka glucocorticoid receptor mediated gene expression. Hoʻopili kēia i ka synthesis o kekahi mau anti-inflammatory protein, ʻoiai ke pale aku nei i ka hoʻohuihui ʻana o kekahi mau mediinal inflammatory.

ʻO ka mea kūikawā, ʻo ka mometasone furoate ka mea e hoʻonāukiuki i ka protein o ka pale o ka phospholipase A2, ma laila e kāohi ai i ka hoʻokuʻu ʻana o ka huakaʻi mua mua o ka huina o ka mua a me ka phospholipase A2.

Reference:

  • 1: Zalmanovici Trestioreanu A, ʻo Yaphe J. Intranasal steroids no ka maʻa sinusitis. Cochrane Pūnaewele Syst Rev. 2013 Dec 2; 12: CD005149. doi: 10.1002 / 14651858.CD005149.pub4. Hoʻopau ʻana. PubMed PMID: 24293353.
  • 2: Ellis AK, North ML, Walker T, Steacy LM. ʻĀpana ʻikeʻike: kahi ʻano kūpono, ʻano kikoʻī a me ka hoʻohālikelike ʻana no ka pilikia allergen. Ann Allergy Asthma Immunol. 2013 Nov; 111 (5): 323-8. doi: 10.1016 / j.anai.2013.07.019. Hoʻopau ʻana. PubMed PMID: 24125135.
  • 3: Lee JT, Han JK. Hoʻopiʻi ka sinus no nā rhinosinusitis mau maʻi: loiloi loiloi. Hoʻomaopopo i ka Opin Drug Deliv. 2013 Dec; 10 (12): 1735-48. doi: 10.1517 / 17425247.2013.839654. Epub 2013 Oct 3. Review. PubMed PMID: 24088141.
  • 4: Nannini LJ, Poole P, Milan SJ, Kesterton A. Ka hoʻohui corticosteroid a me ka beta lōʻihi o ka hana (2) -agonist i loko o hoʻokahi inhaler kūlohelohe corticosteroids wale nō no ka maʻi obstrive maʻi pulmonary obstract. Cochrane Pūnaewele Syst Rev. 2013 Aug 30; 8: CD006826. doi: 10.1002 / 14651858.CD006826.pub2. Hoʻopau ʻana. PubMed PMID: 23990350.

NA HALO A E HOOLAHA:

E kūʻai ʻia ana kēia ʻano mea no ka noiʻi noiʻi wale nō. Wahi a ke kūʻai aku. ʻAʻole no ka loiloi kanaka, ʻaʻole lāʻau lapaʻau, manu hoʻāno, a i ʻole e kōkua ʻia nā mea hale.


COA

HNMR

Nāʻike & nā hua'ōlelo huahana